⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
CSL
BMRN
PFE
LNZA
TMO
MRK
CYN
INCY
GSK
JAZZ
GILD
CELU
OMER
FOUNDATION CONSUMER HEALTHCARE ANNOUNCES SENIOR LEADERSHIP CHANGES FOLLOWING STRATEGIC REPOSITIONING INTO WOMEN'S HEALTH
prnewswire.com
HLN
NVS
MDT
Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy for the Treatment of Peanut Allergy
globenewswire.com
NVS
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure
prnewswire.com
BMY
LLY
NVS
Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027
globenewswire.com
NVS
Global Radiopharmaceutical CDMO Market to Accelerate Substantially at a CAGR of ~10% by 2034 | DelveInsight
globenewswire.com
TMO
MRK
DHR
LNT
THC
GEHC
NVS
LLY
AZN
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
CYTK
NVO
BCDA
AZN
BMY
LLY
MESO
ASMB
LXRX
VTRS
AMGN
IRWD
NVS
MRK
New Ebook Reveals What New CCOs Need to Get Right in the First Six Months
globenewswire.com
ABT
AMST
GIS
KMB
LMT
NVS
SCL
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
prnewswire.com
DBVT
NVS
AQST
GSK
REGN
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN